FDA 483 - Aaron E. Miller, M.D. - April 21, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Aaron E. Miller, M.D. in New York, NY, a clinical investigator, revealed significant deficiencies in the conduct of a clinical trial. Observations included failures to promptly report serious adverse events to the sponsor, multiple instances of not adhering to the investigational protocol, and inadequate record-keeping for investigational drug disposition. These issues indicate a lack of proper oversight and adherence to clinical trial regulations.
ID · c59072b4-3635-4bff-a887-c67406463471